<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000942.v1.p1" parentStudy="phs000942.v1.p1" createDate="2015-06-24" modDate="2015-06-29">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>Theodora S. Ross, MD, PhD</td><td>Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA, and Department of Cancer Genetics, UT Southwestern Medical Center, Dallas, TX, USA</td></tr>
		<tr><td>Institute</td><td>Samantha B. Foley</td><td>Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA</td></tr>
		<tr><td>Institute</td><td>Jonathan J. Rios</td><td>Sarah M. and Charles E. Seay Center for Musculoskeletal Research, Texas Scottish Rite Hospital for Children, Dallas, TX, USA. Department of Pediatrics, 			McDermott Center for Human Growth and Development, and Department of Orthopaedic Surgery, UT Southwestern Medical Center, Dallas, TX, USA</td></tr>
		<tr><td>Institute</td><td>Victoria E. Mgbemena</td><td>Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA</td></tr>
		<tr><td>Institute</td><td>Linda S. Robinson</td><td>Department of Cancer Genetics, UT Southwestern Medical Center, Dallas, TX, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>Use of WGS for Diagnosis and Discovery in the Cancer Genetics Clinic</StudyNameEntrez>
	<StudyNameReportPage>Use of Whole Genome Sequencing for Diagnosis and Discovery in the Cancer Genetics Clinic</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Cohort</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>Despite the potential of whole-genome sequencing (WGS) to improve patient diagnosis and care, the empirical value of WGS in the cancer genetics clinic is unknown. We performed WGS on members of two cohorts of cancer genetics patients: those with BRCA1/2 mutations (n = 176) and those without (n = 82). Initial analysis of potentially pathogenic variants (PPVs, defined as nonsynonymous variants with allele frequency &#60; 1% in ESP6500) in 163 clinically-relevant genes suggested that WGS will provide useful clinical results. This is despite the fact that a majority of PPVs were novel missense variants likely to be classified as variants of unknown significance (VUS). Furthermore, previously reported pathogenic missense variants did not always associate with their predicted diseases in our patients. This suggests that the clinical use of WGS will require large-scale efforts to consolidate WGS and patient data to improve accuracy of interpretation of rare variants. While loss-of-function (LoF) variants represented only a small fraction of PPVs, WGS identified additional cancer risk LoF PPVs in patients with known BRCA1/2 mutations and led to cancer risk diagnoses in 21% of non-BRCA cancer genetics patients after expanding our analysis to 3209 ClinVar genes. These data illustrate how WGS can be used to improve our ability to discover patients&#39; cancer genetic risks. "Reprinted from doi:10.1016/j.ebiom.2014.12.003, with permission from EBioMedicine."</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p>Individuals from the cancer genetics clinics of the University of Texas Southwestern Medical Center (UTSW) and the Ohio State University (OSU) cancer genetics programs were recruited to the study following informed consent approved by the Institutional Review Boards of both institutions. Only unrelated individuals were included in this study. Blood samples were obtained and de-identified. Subsequent genetic results were not returned to participants.</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="25099575"/>
		</Publication>
		<Publication>
			<Pubmed pmid="21677200"/>
		</Publication>
		<Publication>
			<Pubmed pmid="16021471"/>
		</Publication>
		<Publication>
			<Pubmed pmid="22344227"/>
		</Publication>
		<Publication>
			<Pubmed pmid="24941179"/>
		</Publication>
		<Publication>
			<Pubmed pmid="24941182"/>
		</Publication>
		<Publication>
			<Pubmed pmid="24251383"/>
		</Publication>
		<Publication>
			<Pubmed pmid="10213508"/>
		</Publication>
		<Publication>
			<Pubmed pmid="23460708"/>
		</Publication>
		<Publication>
			<Pubmed pmid="24055113"/>
		</Publication>
		<Publication>
			<Pubmed pmid="19892942"/>
		</Publication>
		<Publication>
			<Pubmed pmid="24896178"/>
		</Publication>
		<Publication>
			<Pubmed pmid="9322498"/>
		</Publication>
		<Publication>
			<Pubmed pmid="23788249"/>
		</Publication>
		<Publication>
			<Pubmed pmid="22703879"/>
		</Publication>
		<Publication>
			<Pubmed pmid="24487276"/>
		</Publication>
		<Publication>
			<Pubmed pmid="24733792"/>
		</Publication>
		<Publication>
			<Pubmed pmid="20719861"/>
		</Publication>
		<Publication>
			<Pubmed pmid="17942008"/>
		</Publication>
		<Publication>
			<Pubmed pmid="22699143"/>
		</Publication>
		<Publication>
			<Pubmed pmid="23035047"/>
		</Publication>
		<Publication>
			<Pubmed pmid="24319668"/>
		</Publication>
		<Publication>
			<Pubmed pmid="23622139"/>
		</Publication>
		<Publication>
			<Pubmed pmid="24510652"/>
		</Publication>
		<Publication>
			<Pubmed pmid="21173700"/>
		</Publication>
		<Publication>
			<Pubmed pmid="25318351"/>
		</Publication>
		<Publication>
			<Pubmed pmid="12645648"/>
		</Publication>
		<Publication>
			<Pubmed pmid="12545165"/>
		</Publication>
		<Publication>
			<Pubmed pmid="26023681"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Neoplasms"/>
		<Disease vocab_source="MESH" vocab_term="Breast Neoplasms"/>
		<Disease vocab_source="MESH" vocab_term="Ovarian Neoplasms"/>
		<Disease vocab_source="MESH" vocab_term="Peritoneal Neoplasms"/>
		<Disease vocab_source="MESH" vocab_term="Skin Neoplasms"/>
		<Disease vocab_source="MESH" vocab_term="Esophageal Neoplasms"/>
		<Disease vocab_source="MESH" vocab_term="Thyroid Neoplasms"/>
		<Disease vocab_source="MESH" vocab_term="Urinary Bladder Neoplasms"/>
		<Disease vocab_source="MESH" vocab_term="Endometrial Neoplasms"/>
		<Disease vocab_source="MESH" vocab_term="Fallopian Tube Neoplasms"/>
		<Disease vocab_source="MESH" vocab_term="Melanoma"/>
		<Disease vocab_source="MESH" vocab_term="Testicular Neoplasms"/>
		<Disease vocab_source="MESH" vocab_term="Bile Duct Neoplasms"/>
		<Disease vocab_source="MESH" vocab_term="Lung Neoplasms"/>
		<Disease vocab_source="MESH" vocab_term="Colonic Neoplasms"/>
		<Disease vocab_source="MESH" vocab_term="Adrenocortical Carcinoma"/>
		<Disease vocab_source="MESH" vocab_term="Carcinoma, Renal Cell"/>
		<Disease vocab_source="MESH" vocab_term="Colonic Polyps"/>
		<Disease vocab_source="MESH" vocab_term="Adenomatous Polyposis Coli"/>
		<Disease vocab_source="MESH" vocab_term="Lymphoma, Large B-Cell, Diffuse"/>
		<Disease vocab_source="MESH" vocab_term="Pheochromocytoma"/>
		<Disease vocab_source="MESH" vocab_term="Paraganglioma"/>
		<Disease vocab_source="MESH" vocab_term="Leiomyoma"/>
		<Disease vocab_source="MESH" vocab_term="Hemangioblastoma"/>
		<Disease vocab_source="MESH" vocab_term="Hyperparathyroidism"/>
		<Disease vocab_source="MESH" vocab_term="Pancreatic Neoplasms"/>
		<Disease vocab_source="MESH" vocab_term="Vulvar Neoplasms"/>
		<Disease vocab_source="MESH" vocab_term="Brain Neoplasms"/>
		<Disease vocab_source="MESH" vocab_term="Liver Neoplasms"/>
		<Disease vocab_source="MESH" vocab_term="Kidney Neoplasms"/>
		<Disease vocab_source="MESH" vocab_term="Prostatic Neoplasms"/>
		<Disease vocab_source="MESH" vocab_term="Glioblastoma"/>
		<Disease vocab_source="MESH" vocab_term="Oncocytoma, renal"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>Theodora S. Ross, MD, PhD</AttName>
			<Institution>Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA, and Department of Cancer Genetics, UT Southwestern Medical Center, Dallas, TX, USA</Institution>
		</Header>
		<Header title="Institute">
			<AttName>Samantha B. Foley</AttName>
			<Institution>Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA</Institution>
		</Header>
		<Header title="Institute">
			<AttName>Jonathan J. Rios</AttName>
			<Institution>Sarah M. and Charles E. Seay Center for Musculoskeletal Research, Texas Scottish Rite Hospital for Children, Dallas, TX, USA. Department of Pediatrics, 			McDermott Center for Human Growth and Development, and Department of Orthopaedic Surgery, UT Southwestern Medical Center, Dallas, TX, USA</Institution>
		</Header>
		<Header title="Institute">
			<AttName>Victoria E. Mgbemena</AttName>
			<Institution>Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA</Institution>
		</Header>
		<Header title="Institute">
			<AttName>Linda S. Robinson</AttName>
			<Institution>Department of Cancer Genetics, UT Southwestern Medical Center, Dallas, TX, USA</Institution>
		</Header>
		<Header title="Institute">
			<AttName>Heather L. Hampel</AttName>
			<Institution>Department of Human Genetics, Ohio State University, Columbus, OH, USA</Institution>
		</Header>
		<Header title="Institute">
			<AttName>Amanda E. Toland</AttName>
			<Institution>Department of Human Genetics, Ohio State University, Columbus, OH, USA</Institution>
		</Header>
		<Header title="Institute">
			<AttName>Leslie Durham</AttName>
			<Institution>Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>Clinical Scientist Award ID# 1007448</AttName>
			<Institution>Burroughs Wellcome Fund, Research Triangle Park, NC, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>Jeanne Ann Plitt Professorship in Breast Cancer Research, Dallas, TX, USA</AttName>
			<Institution>UT Southwestern Medical Center, Dallas, TX, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>H. Ben and Isabelle T. Decherd Chair in Internal Medicine, Dallas, TX, USA</AttName>
			<Institution>UT Southwestern Medical Center, Dallas, TX, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>UL1TR001105</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<StudyHistory><![CDATA[
<p>First samples collected March 2003. Additional patients recruited at Ohio State University, Columbus, OH, and University of Texas Southwestern Medical Center, Dallas, TX, continued through 2013. First samples submitted to Complete Genomics, Inc. in December 2012. Study ended October 2014.</p>]]>
	</StudyHistory>
	<ConsentGroups>
		<ConsentGroup groupNum="0" shortName="NRUP" longName="Subjects did not participate in the study, did not complete a consent document and are included only for the pedigree structure and/or genotype controls, such as HapMap subjects"/>
		<ConsentGroup groupNum="1" shortName="GRU-PUB-MDS" longName="General Research Use (PUB, MDS)"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NCI</DacName>
      <DacFullName>NCI</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000942.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>0</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000942.v1.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000942.v1.p1" FileName=""/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>General Research Use (PUB, MDS)</ConsentName>
        <ConsentAbbrev>GRU-PUB-MDS</ConsentAbbrev>
        <UseLimitation>Use of the data is limited only by the terms of the model Data Use Certification.
Requestor agrees to make results of studies using the data available to the larger scientific community.
Use of the data includes methods development research (e.g., development of software or algorithms).</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>


</Study>

</Studies>

</GaPExchange>
